Perrigo Company plc (PRGO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Perrigo Company plc (PRGO:NYSE), powered by AI.

Current Price
$10.67
P/E Ratio
-1.0
Market Cap
1.5B
Sector
Healthcare
What is the Perrigo Company plc stock price forecast?

Perrigo Company plc is currently trading at $10.67. View real-time AI analysis on Alpha Lenz.

What is Perrigo Company plc insider trading activity?

View the latest insider trading data for Perrigo Company plc on Alpha Lenz.

What is Perrigo Company plc's P/E ratio?

Perrigo Company plc's P/E ratio is -1.0.

Perrigo Company plc

NYSE · PRGO
$10.67-0.03(-0.28%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Perrigo Company plc's future dividend policy...
Alpha Chat Insight

Perrigo Company plc trades at a P/E of -1.0 (undervalued) with modest ROE of -39.3%.

Ask for details

Company Overview

Perrigo Company plc is a leading global provider in the pharmaceutical industry, primarily focused on manufacturing and distributing over-the-counter (OTC) consumer healthcare products. As a prominent player in the sector, Perrigo specializes in developing products that promote wellness and self-care, including vitamins, dietary supplements, and personal care items. Perrigo plays a crucial role in enhancing accessibility to health products by producing high-quality, affordable alternatives to brand-name drugs. This approach caters to a broad consumer base by providing options that are both effective and cost-efficient. Headquartered in Dublin, Ireland, Perrigo serves numerous markets across the world, impacting various industries by collaborating with healthcare institutions and retail channels. The company is recognized for its commitment to innovation and quality assurance, continuously adapting products to meet evolving consumer needs and regulatory standards. Perrigo's significant contributions to the pharmaceutical field underscore its importance in the global effort to improve public health and wellness through accessible and reliable healthcare solutions.

CEOMr. Patrick Lockwood-Taylor
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees8,379

Company Statistics

FY 2025

Profile

$1.48BMarket Cap
$4.25BRevenue
0.00Shares Out
8,379Employees

Margins

35.14%Gross
14.98%EBITDA
7.35%Operating
-30.52%Pre-Tax
-33.51%Net

Valuation

-1.04P/E
0.50P/B
0.35EV/Sales
7.20EV/EBITDA
10.18P/FCF

Growth (CAGR)

-1.51%Rev 3Yr
0.79%Rev 5Yr
37.09%Op Inc 3Yr
3.11%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-15.68%ROA
-39.29%ROE
-12.49%ROIC

Financial Health

$531.60MCash & Cash Equivalents
$5.07BNet Debt
190.76%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Perrigo Company plc (ticker: PRGO) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 8,379 employees. Market cap is $1.5B.

The current price is $10.67 with a P/E ratio of -1.04x and P/B of 0.5x.

ROE is -39.29% and operating margin is 7.35%. Annual revenue is $4.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Perrigo Company plc (PRGO) Stock Forecast 2026 $10.67 — Price, Financials & Analyst Targets | Alpha Lenz